Table 2.
Univariate meta-regression analysis between effect size and possible contributors to heterogeneity.
Number of studies | t | p-value | Explained heterogeneity | |
---|---|---|---|---|
Age | 54 | 0.43 | 0.67 | 0% |
Gender | 54 | −0.54 | 0.59 | 0% |
Time of recruitment commencement | 54 | 1.44 | 0.15 | 3% |
White blood cell count | 44 | 3.51 | 0.001 | 22% |
C-reactive protein | 46 | 1.17 | 0.25 | 1% |
Procalcitonin | 23 | 1.75 | 0.10 | 9% |
Aspartate aminotransferase | 47 | 2.81 | 0.007 | 15% |
Alanine aminotransferase | 48 | −0.73 | 0.47 | 0% |
Albumin | 37 | −1.53 | 0.13 | 4% |
D-dimer | 40 | 2.47 | 0.02 | 13% |
Troponin | 26 | 3.83 | 0.001 | 39% |
Myoglobin | 17 | 2.91 | 0.01 | 36% |
Brain natriuretic peptide | 19 | 2.67 | 0.02 | 29% |
Creatinine | 43 | 1.17 | 0.25 | 5% |
Lactate dehydrogenase | 34 | 2.40 | 0.02 | 15% |
Diabetes | 37 | 0.56 | 0.58 | 0% |
Cardiovascular disease | 34 | −0.80 | 0.43 | 0% |
Hypertension | 39 | 0.59 | 0.56 | 0% |